Effects of Topically Delivered Benzamil and Amiloride on Nasal Potential Difference in Cystic Fibrosis
Authors:
- 1 June 1998
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 157 (6) , 1844-1849
Abstract
The raised nasal transepithelial potential difference (PD) in cystic fibrosis (CF) reflects accelerated active transport of Na+, and is inhibited by topical administration of the Na+ channel blocker, amiloride. The aim of this study was to investigate the dose-effect and time course of topically administered Na+ conductance inhibitors to inhibit nasal PD, including benzamil, an analog of amiloride. We measured the magnitude of drug inhibition of Na+ transport [percent inhibition of baseline PD ( Δ PD%)] and duration of inhibition of PD, defined as the time when drug inhibition of PD had recovered by 50% (effective time = ET50). Amiloride [10− 3 M (n = 16), 3 × 10− 3 M (n = 9), 6 × 10− 3 M (n = 7), 10− 2 M (n = 3)] or benzamil [1.7 × 10− 3 M (n = 7), and 7 × 10− 3 M (n = 5)] were administered to the nasal surface via an aerosol generated by a jet nebulizer and a nasal mask. The concentration-dependent magnitude ( Δ PD%) of inhibition was similar for amiloride and benzamil ( ∼ 67– 77%), whereas the duration of inhibition (ET50) was about two-and-a-half times longer after benzamil administration as compared with equivalent concentrations of amiloride [1.6 ± 0.06 versus 4.5 ± 0.6 h (ET50 ± SEM), at 6–7 × 10− 3 M]. In vitro studies of cultured normal nasal epithelia demonstrated directly that benzamil induced an approximately 2-fold more prolonged inhibition of active Na+ transport than amiloride. These data suggest aerosolized benzamil is a candidate long-duration Na+ channel blocker for CF.Keywords
This publication has 23 references indexed in Scilit:
- Aerosolized Amiloride: Dose Effect on Nasal Bioelectric Properties, Pharmacokinetics, and Effect on Sputum Expectoration in Patients with Cystic FibrosisJournal of Aerosol Medicine, 1997
- Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial.Archives of Disease in Childhood, 1995
- Effects of Benzamil in Human Cystic Fibrosis Airway EpitheliumCellular Physiology and Biochemistry, 1995
- Amiloride Inhalation Therapy in Cystic Fibrosis: Influence on Ion Content, Hydration, and Rheology of SputumAmerican Review of Respiratory Disease, 1993
- Generation of cAMP-Activated Chloride Currents by Expression of CFTRScience, 1991
- A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic FibrosisNew England Journal of Medicine, 1990
- Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis.Thorax, 1987
- Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation.Journal of Clinical Investigation, 1986
- Relative ion permeability of normal and cystic fibrosis nasal epithelium.Journal of Clinical Investigation, 1983
- Increased Bioelectric Potential Difference across Respiratory Epithelia in Cystic FibrosisNew England Journal of Medicine, 1981